Objective:
To explore how decision intelligence can enhance glaucoma management through improved data integration and personalized care.
Key Findings:
- Glaucoma often progresses asymptomatically, leading to late detection and treatment.
- Current care practices are fragmented, making it difficult to synthesize information for timely decisions.
- Decision intelligence can enhance diagnostic accuracy and personalize treatment by integrating diverse data sources.
Interpretation:
Integrating decision intelligence into glaucoma care can bridge the gap between abundant data and effective clinical decisions, ultimately improving patient outcomes.
Limitations:
- Implementation of decision intelligence requires significant changes in clinical workflows.
- Data fragmentation across platforms may still pose challenges even with advanced analytics.
Conclusion:
Adopting decision intelligence in glaucoma care can lead to more proactive, personalized management, reducing preventable vision loss.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







